Impact of the angiotensin receptor-neprilysin inhibitor on chronic heart failure due to adult congenital heart disease: A systematic review and meta-analysis
Open Access
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Safety and Treatment Experience With Sodium/glucose Cotransporter-2 Inhibitors in Adult Patients With Congenital Heart DiseaseJournal of Cardiac Failure, 2023
- Sacubitril/valsartan reverses cardiac structure and function in experimental model of hypertension-induced hypertrophic cardiomyopathyMolecular and Cellular Biochemistry, 2023
- Outcomes and Healthcare Resource Utilization in Adult Congenital Heart Disease Patients with Heart FailureESC Heart Failure, 2021
- Heart Failure Related to Adult Congenital Heart Disease: Prevalence, Outcome and Risk FactorsESC Heart Failure, 2021
- Tolerability and Effect of Angiotensin Receptor Neprilysin Inhibitors in Adult Congenital Patients with Systemic Right VentricleJournal of Cardiac Failure, 2020
- Initial Experience in Adults with Complex Congenital Heart Disease Treated with Sacubitril/Valsartan for Heart FailureThe Journal of Heart and Lung Transplantation, 2020
- Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE-HF)American Heart Journal, 2018
- Afterload Reduction Therapy in Patients Following Intraatrial Baffle Operation for Transposition of the Great ArteriesPediatric Cardiology, 2002
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000